These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25571261)

  • 1. Development of a specific tracer for metabolic imaging of alveolar echinococcosis: A preclinical study.
    Porot C; Knapp J; Wang J; Germain S; Camporese D; Seimbille Y; Boulahdour H; Vuitton DA; Gottstein B; Blagosklonov O
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5587-90. PubMed ID: 25571261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
    Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL
    Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography.
    Ehrhardt AR; Reuter S; Buck AK; Haenle MM; Mason RA; Gabelmann A; Kern P; Kratzer W
    Abdom Imaging; 2007 Nov; 32(6):730-6. PubMed ID: 17285403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis.
    Caoduro C; Porot C; Vuitton DA; Bresson-Hadni S; Grenouillet F; Richou C; Boulahdour H; Blagosklonov O
    J Nucl Med; 2013 Mar; 54(3):358-63. PubMed ID: 23303963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Metabolic Activity of Echinococcus multilocularis in Rodents Using Positron Emission Tomography Tracers.
    Rolle AM; Soboslay PT; Reischl G; Hoffmann WH; Pichler BJ; Wiehr S
    Mol Imaging Biol; 2015 Aug; 17(4):512-20. PubMed ID: 25561014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones.
    Liu W; Delabrousse É; Blagosklonov O; Wang J; Zeng H; Jiang Y; Wang J; Qin Y; Vuitton DA; Wen H
    Parasite; 2014; 21():74. PubMed ID: 25531446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity.
    Azizi A; Blagosklonov O; Lounis A; Berthet L; Vuitton DA; Bresson-Hadni S; Delabrousse E
    Abdom Imaging; 2015 Jan; 40(1):56-63. PubMed ID: 24970734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-Weighted MRI for the Initial Viability Evaluation of Parasites in Hepatic Alveolar Echinococcosis: Comparison with Positron Emission Tomography.
    Zheng J; Wang J; Zhao J; Meng X
    Korean J Radiol; 2018; 19(1):40-46. PubMed ID: 29353998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography.
    Reuter S; Schirrmeister H; Kratzer W; Dreweck C; Reske SN; Kern P
    Clin Infect Dis; 1999 Nov; 29(5):1157-63. PubMed ID: 10524957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
    Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M
    Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity.
    Brumpt E; Blagosklonov O; Calame P; Bresson-Hadni S; Vuitton DA; Delabrousse E
    Infection; 2019 Dec; 47(6):955-960. PubMed ID: 31165442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET/MRI imaging for the management of alveolar echinococcosis: initial clinical experience at a reference centre in Austria.
    Lötsch F; Waneck F; Groger M; Auer H; Kaczirek K; Rausch I; Wadsak W; Hacker M; Lagler H; Ramharter M; Karanikas G
    Trop Med Int Health; 2019 Jun; 24(6):663-670. PubMed ID: 30851233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic alveolar echinococcosis: correlation between computed tomography morphology and inflammatory activity in positron emission tomography.
    Graeter T; Eberhardt N; Shi R; Schmidberger J; Beer AJ; Beer M; Henne-Bruns D; Hillenbrand A; Barth TFE; Grimm J; Kratzer W; Gruener B
    Sci Rep; 2020 Jul; 10(1):11808. PubMed ID: 32678174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of range and metabolic activity of hepatic alveolar echinococcosis lesion microenvironment using PET/CT and multi-site sampling method.
    Aini A; Yimingjiang M; Yasen A; Ran B; Jiang T; Li X; Wang J; Abulizi A; Li Z; Shao Y; Aji T; Wen H
    BMC Infect Dis; 2021 Jul; 21(1):702. PubMed ID: 34301188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
    Wang FL; Tan YY; Gu XM; Li TR; Lu GM; Liu G; Huo TL
    Chin Med J (Engl); 2016 Dec; 129(24):2926-2935. PubMed ID: 27958224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [
    Li J; Dong J; Yang L; Li X; Song T
    Ultrasound Med Biol; 2018 Nov; 44(11):2199-2208. PubMed ID: 30077410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study.
    Rybka J; Małkowski B; Olejniczak M; Chmielowska E; Sokołowska E; Kuliczkowski K; Wróbel T
    Adv Clin Exp Med; 2019 Aug; 28(8):1095-1099. PubMed ID: 31237123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Body 18 F-FDG PET/CT Patlak Parametric Imaging of Hepatic Alveolar Echinococcosis.
    Maurer A; Kotasidis F; Deibel A; Burger IA; Huellner MW
    Clin Nucl Med; 2023 Dec; 48(12):1089-1090. PubMed ID: 37801583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.